Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5289
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
HUMIRA 40MG INJ SOL 4X0,8ML I
0025567 EU/1/03/256/004 humira.pdf humira.pdf L04AB04 R
HUMIRA 40MG INJ SOL 6X0,8ML I
0025568 EU/1/03/256/005 humira.pdf humira.pdf L04AB04 R
HUMIRA K PEDIATRICKÉMU UŽITÍ 40MG/0,8ML INJ SOL 2X(0,8ML+STŘ+1J+AD)
0025564 EU/1/03/256/001 humirakped.pdf humirakped.pdf L04AB04 R
HYCAMTIN 1MG CPS DUR 10
0029338 EU/1/96/027/007 hycamtin.pdf hycamtin.pdf L01CE01 R
HYCAMTIN 1MG INF PLV CSL 5
0025625 EU/1/96/027/004 hycamtin.pdf hycamtin.pdf L01CE01 R
HYCAMTIN 4MG INF PLV CSL 1
0025624 EU/1/96/027/003 hycamtin.pdf hycamtin.pdf L01CE01 R
HYCAMTIN 4MG INF PLV CSL 5
0025622 EU/1/96/027/001 hycamtin.pdf hycamtin.pdf L01CE01 R
HYCAMTIN 1MG INF PLV CSL 1
0025626 EU/1/96/027/005 hycamtin.pdf hycamtin.pdf L01CE01 R
HYCAMTIN 0,25MG CPS DUR 10
0029337 EU/1/96/027/006 hycamtin.pdf hycamtin.pdf L01CE01 R
HYRIMOZ 40MG INJ SOL 1X0,8ML ISP
0223020 EU/1/18/1286/001 hyrimoz.pdf hyrimoz.pdf L04AB04 R
HYRIMOZ 40MG INJ SOL 2X0,8ML ISP
0223021 EU/1/18/1286/002 hyrimoz.pdf hyrimoz.pdf L04AB04 R
HYRIMOZ 40MG INJ SOL 6(3X2)X0,8ML ISP
0223022 EU/1/18/1286/003 hyrimoz.pdf hyrimoz.pdf L04AB04 R
HYRIMOZ 20MG INJ SOL 2X0,4ML ISP
0238902 EU/1/18/1286/007 hyrimoz.pdf hyrimoz.pdf L04AB04 R
HYRIMOZ 40MG INJ SOL 2X0,8ML PEP
0223024 EU/1/18/1286/005 hyrimoz.pdf hyrimoz.pdf L04AB04 R
HYRIMOZ 40MG INJ SOL 6(3X2)X0,8ML PEP
0223025 EU/1/18/1286/006 hyrimoz.pdf hyrimoz.pdf L04AB04 R
HYRIMOZ 40MG INJ SOL 1X0,8ML PEP
0223023 EU/1/18/1286/004 hyrimoz.pdf hyrimoz.pdf L04AB04 R
IBRANCE 75MG CPS DUR 21
0219105 EU/1/16/1147/001 ibrance.pdf ibrance.pdf L01EF01 R
IBRANCE 125MG TBL FLM 21 II
0255060 EU/1/16/1147/018 ibrance.pdf ibrance.pdf L01EF01 R
IBRANCE 100MG CPS DUR 21
0219107 EU/1/16/1147/003 ibrance.pdf ibrance.pdf L01EF01 R
IBRANCE 100MG CPS DUR 21
0219108 EU/1/16/1147/004 ibrance.pdf ibrance.pdf L01EF01 R

‹‹ ‹ 50 60 70 80 90 91 92 93 94 95 96 97 98 99 100 101 110 120 130 140 150 200 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 18. January 2022 at 00:08
Last update of price and payment data: 1. January 2022 at 00:11